How many institutions held FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in Q1 2021?

251 institutional investors reported FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q: What does CUSIP 31189P102 represent in this 13F holders report?

CUSIP 31189P102 is the security identifier for FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 31189P102

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 122,342,805
Total 13F shares: 93,763,343
Share change: +6,756,194
Total reported value: $7,731,987,612
Put/Call ratio: 121%
Price per share: $82.45
Number of holders: 251
Value change: +$546,947,235
Number of buys: 133
Number of sells: 123

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 31189P102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	10%	12,629,737	$1,148,422,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	6.2%	7,604,904	$691,514,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	5.5%	6,778,587	$616,376,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	5.5%	6,671,541	$606,642,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.9%	3,510,970	$319,253,000	—	31 Dec 2020	13F
Johnson & Johnson Innovation - JJDC, Inc.	13F	Company	2.8%	3,379,064	$307,258,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	2.5%	3,050,000	$277,337,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	2.5%	3,000,000	$272,790,000	—	31 Dec 2020	13F
ARK Investment Management LLC	13F	Company	2.4%	2,901,700	$263,852,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.1%	2,545,568	$231,467,000	—	31 Dec 2020	13F
Bellevue Group AG	13F	Company	1.7%	2,107,500	$191,635,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.7%	2,107,373	$191,623,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.4%	1,751,455	$159,260,000	—	31 Dec 2020	13F
Grosvenor Holdings, L.L.C.	13F	Company	1.2%	1,459,517	$132,714,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	1.1%	1,400,000	$127,302,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.95%	1,159,514	$105,434,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.91%	1,108,640	$100,809,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.79%	972,593	$88,438,000	—	31 Dec 2020	13F
Darwin Global Management, Ltd.	13F	Company	0.78%	952,847	$86,642,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.73%	893,368	$81,234,000	—	31 Dec 2020	13F
LONE PINE CAPITAL LLC	13F	Company	0.72%	883,666	$80,352,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.69%	840,713	$76,446,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.63%	775,414	$70,509,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.63%	775,357	$70,503,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.62%	759,493	$69,062,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.62%	754,942	$68,647,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.49%	600,002	$54,558,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.49%	598,269	$54,401,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.48%	592,253	$53,854,000	—	31 Dec 2020	13F
Polaris Venture Management Co. V, L.L.C.	13F	Company	0.47%	569,889	$51,820,000	—	31 Dec 2020	13F
Amova Asset Management Americas, Inc.	13F	Company	0.44%	537,664	$48,890,000	—	31 Dec 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.44%	537,664	$48,890,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.39%	480,428	$43,686,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.38%	464,754	$42,260,000	—	31 Dec 2020	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.35%	434,086	$39,471,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.35%	423,856	$38,541,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.34%	410,425	$37,319,945	—	31 Dec 2020	13F
Eversept Partners, LP	13F	Company	0.33%	399,499	$36,326,444	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.32%	396,157	$36,022,000	—	31 Dec 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.32%	387,327	$35,220,000	—	31 Dec 2020	13F
DAFNA Capital Management LLC	13F	Company	0.27%	334,360	$30,403,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.26%	322,342	$29,311,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.26%	315,223	$28,663,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	309,951	$28,184,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.22%	270,111	$24,562,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.22%	264,639	$24,063,000	—	31 Dec 2020	13F
Ally Bridge Group (NY) LLC	13F	Company	0.21%	260,000	$23,642,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.21%	252,601	$22,969,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.19%	227,731	$20,707,000	—	31 Dec 2020	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.17%	202,279	$18,393,000	—	31 Dec 2020	13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2021

As of 31 Mar 2021, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 251 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,763,343 shares. The largest 10 holders included Redmile Group, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., ARK Investment Management LLC, Casdin Capital, LLC, Johnson & Johnson Innovation - JJDC, Inc., PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, and STATE STREET CORP. This page lists 252 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

247

Q1 2021 holders

251

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.